Pharmacy Department, Queen Elizabeth University Hospital, Glasgow, UK
Pharmacy Department, Glasgow Royal Infirmary, Glasgow, UK.
Eur J Hosp Pharm. 2024 Jun 21;31(4):321-326. doi: 10.1136/ejhpharm-2022-003573.
Elective surgery suffered significant loss of capacity during the COVID-19 pandemic. To address this, hip and knee arthroplasties are being conducted as day case procedures. Pre-admission pharmacist consultations were introduced (the intervention) for these patients. This consultation aimed to address perioperative medicines issues, promote patient empowerment, improve prescribing quality and contribute to reduction in length of stay (LoS).
All patients listed for a total/unicompartmental knee replacement (TKR/UKR) or total hip replacement (THR) at an ambulatory care hospital were identified by a pharmacist prescriber 1-2 weeks before the operation. Pharmacist consultations were conducted remotely with discharge prescriptions written electronically and dispensed before admission. Prescribing data were collected for both pre-intervention (n=80) and post-intervention (n=129) groups along with all interventions undertaken during consultations. Staff opinion was sought via online questionnaire and patient opinion was gathered via post-discharge telephone calls.
A total of 115 interventions took place during 129 patient consultations and >75% of interventions were of a significance expected to improve patient care. Prescribing standards were improved in the intervention group compared with patients whose arthroplasty was before the introduction of this service. The pharmacy service would have produced a different prescription in 38.8% of the pre-intervention group. Staff and patient feedback was extremely positive and all patients with previous surgical experience in the health board reported an improved experience. There was a statistically significant reduction in post-discharge healthcare encounters (such as general practitioner (GP) visits) in the intervention group.
This novel remote preoperative pharmacist consultation improved prescribing standards, enhanced the patient's surgical experience and reduced the burden on post-discharge healthcare systems.
在 COVID-19 大流行期间,择期手术遭受了严重的能力损失。为了解决这个问题,髋关节和膝关节置换术正在作为日间手术进行。为这些患者引入了术前药剂师咨询(干预)。这次咨询旨在解决围手术期用药问题,增强患者的自主权,提高处方质量,并有助于缩短住院时间(LoS)。
通过药剂师处方者在手术前 1-2 周识别出在门诊医院接受全膝关节置换术(TKR/UKR)或全髋关节置换术(THR)的所有患者。药剂师咨询是远程进行的,出院处方是电子书写的,并在入院前配药。收集了干预前(n=80)和干预后(n=129)两组的所有干预措施以及所有干预措施的数据。通过在线问卷征求了工作人员的意见,并通过出院后的电话收集了患者的意见。
在 129 次患者咨询中进行了总共 115 次干预,超过 75%的干预措施具有预期可以改善患者护理的意义。与在引入这项服务之前接受关节置换术的患者相比,干预组的处方标准得到了改善。在干预组中,药房服务本可以在 38.8%的情况下开出不同的处方。工作人员和患者的反馈非常积极,该卫生委员会所有有过手术经验的患者都报告说体验得到了改善。干预组在出院后的医疗保健方面(如全科医生(GP)就诊)的就诊次数有统计学显著减少。
这种新颖的远程术前药剂师咨询改善了处方标准,增强了患者的手术体验,并减轻了出院后医疗系统的负担。